NasdaqGM:MRUSBiotechs
Did Rising Nine-Month Losses and Modest Revenue Growth Just Shift Merus' (MRUS) Investment Narrative?
Merus N.V. reported its third quarter 2025 earnings, showing revenue of US$12.15 million and a net loss of US$95.52 million, with the nine-month loss rising to US$350.21 million on revenue of US$47.47 million.
While quarterly revenues edged up from last year, losses for the nine-month period grew dramatically as reported on October 31, 2025.
We'll examine how Merus' ramp-up in nine-month revenues alongside widening losses shapes its current investment narrative.
The end of cancer? These 29...